According to the American Cancer Society, lung cancer is the deadliest cancer in the United States and the second most common type of cancer. A promising new approach could change that: advanced ...
Add Yahoo as a preferred source to see more of our stories on Google. Picture this: Your doctor orders an imaging test like a chest X-ray in preparation for an upcoming procedure, and the results show ...
Please provide your email address to receive an email when new articles are posted on . The negative predictive value of a biomarker that detects benign vs. malignant nodules was more than 90% in men ...
Incidental pulmonary nodules are a common finding on chest imaging, but one program is taking an uncommon approach to managing them. Incidental nodules present a growing diagnostic and management ...
Background: In the screening of pulmonary subsolid nodules (SSNs), it is crucial to compare the quantitative parameters under consistent computed tomography (CT) acquisition conditions, including the ...
Studies highlight the clinical utility and real-world impact of the Nodify CDT® and Nodify XL2® tests in managing both benign and malignant pulmonary nodules. Dr. Kurman, remarked, "The data we're ...
It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced that new data will be presented at the CHEST Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results